|

Early Ageing During Therapy in AYA Cancer Patients

RECRUITINGSponsored by University Medical Center Groningen
Actively Recruiting
SponsorUniversity Medical Center Groningen
Started2022-02-10
Est. completion2025-07
Eligibility
Age18 Years – 39 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05062707

Summary

Longitudinal cohort study; measurements before start of systemic therapy and one year later.

Eligibility

Age: 18 Years – 39 YearsHealthy volunteers accepted
Inclusion Criteria:

* Aged 18-39 years at cancer diagnosis
* Having a histologically and/or cytologically confirmed cancer diagnosis, including leukemia, (non-)Hodgkin lymphoma, testicular cancer, osteosarcoma, Ewing sarcoma, breast cancer, and cervical cancer.
* Scheduled to start systemic therapy with curative intent. Allowed treatments (concurrent or sequential) are: surgery, radiotherapy, chemotherapy, antibodies.

Exclusion Criteria:

* patients who are not able to understand the patient information letter and informed consent form
* patients who will be treated with immune checkpoint inhibitors or targeted therapy with inhibitors of angiogenesis
* patients who have been treated with systemic therapy or radiotherapy for a previous malignancy (exceptions: in situ carcinoma of the cervix or uterus and adequately treated basal and squamous cell carcinoma of the skin).

Conditions8

Breast CancerCancerCervical CancerEwing SarcomaHodgkin LymphomaLeukemiaOsteosarcomaTesticular Cancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.